About Phenox
Phenox is a company based in Bochum (Germany) founded in 2005 was acquired by Wallaby Medical in April 2022. Phenox offers products and services including HPC Coating, pRESET, and Flow Diverter. Phenox operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
- Headquarter Bochum, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Phenox Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
NRW.Bank
& 2 more
-
Employee Count
Not available
-
Acquired by
Wallaby Medical
(Apr 26, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Phenox
Phenox offers a comprehensive portfolio of products and services, including HPC Coating, pRESET, and Flow Diverter.
Hydrophilic polymer that reduces thrombosis on implants.
Device for ischemic stroke management.
Implant to treat aneurysms with reduced thrombosis risk.
Funding Insights of Phenox
Investors in Phenox
Phenox has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, Wallaby Medical and SHS Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Locked | Locked | Locked | |
|
Loans, advice, seminars, and networks are provided for financial support.
|
Locked | Locked | Locked | |
|
A medical device for stroke treatment is developed.
|
Locked | Locked | Locked |
Investor details for Phenox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phenox
Investment portfolio details for Phenox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Phenox
Detailed financials for Phenox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phenox Comparisons
Peer comparison for Phenox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Phenox
Phenox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| Locked | Locked | Locked |
Catheter-based treatment for cerebral ischemia
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| Locked | Locked | Locked |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| Locked | Locked | Locked |
Metallic mesh devices for brain aneurysms are developed.
|
|
| Locked | Locked | Locked |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
Detailed competitors of Phenox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phenox
Complete news archive for Phenox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phenox
Phenox was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Phenox is headquartered in Bochum, Germany. It is registered at Bochum, North Rhine-westphalia, Germany.
Phenox was founded in 2005 and is based in Bochum, Germany. Medical devices for interventional neurology are developed by the company, focusing on treatments for aneurysms and acute ischemic stroke. Key products include the p64 flow modulation device, pCONus bifurcation aneurysm implant for wide-neck aneurysms, pREset LITE thrombectomy device, and pITA rapid exchange neurovascular PTA balloon catheter. Operations center on innovation in neurovascular interventions.
Phenox's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Phenox offers HPC Coating, pRESET, and Flow Diverter.
Phenox has 3 investors. Key investors include NRW.Bank, Wallaby Medical, and SHS Capital.